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Abstract
How the proto-oncogene c-Myc balances the processes of stem cell self-renewal, proliferation and
differentiation in adult tissues is largely unknown. We explored c-Myc’s transcriptional roles at
the Epidermal Differentiation Complex (EDC) a locus essential for skin maturation. Binding of c-
Myc can simultaneously recruit (Klf4, Ovo1-1) and displace (C/EBPα, Mxi1 and Sin3A) specific
sets of differentiation-specific transcriptional regulators to EDC genes. We found that Sin3A
causes de-acetylation of c-Myc protein to directly repress c-Myc activity. In the absence of Sin3A,
genomic recruitment of c-Myc to the EDC is enhanced, and re-activation of c-Myc-target genes
drives aberrant epidermal proliferation and differentiation. Simultaneous deletion of c-Myc and
Sin3A reverts the skin phenotype to normal. Our results identify how the balance of two
transcriptional key regulators can maintain tissue homeostasis via a negative feedback loop.
Introduction
The wide-ranging biological roles of Myc oncogenes in normal and cancer cells has made c-
Myc one of the most exhaustively studied genes, yet a unifying view on its functions has
proven elusive 1. c-Myc and its often redundant paralogs modulate diverse and sometimes
opposing cellular functions including cell growth and proliferation, metabolism,
differentiation and apoptosis 2,3. Inhibition of all Myc proteins in somatic tissues with rapid
turnover, including skin, bone, intestine and testis triggers a marked reduction in cellular
proliferation 4. In some of these adult tissues, c-Myc is as a central regulator of self-renewal,
proliferation and differentiation processes 2,5-9.
c-Myc may control multiple biological functions by direct regulation of two distinct sets of
target genes: (i) those broadly involved in cell proliferation and growth, and (ii) those
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expressed tissue-specifically 1,2,10. For instance, c-Myc forces skin stem cells to exit their
niche by reducing the adhesive interactions 11. Across the epidermis, c-Myc promotes
proliferation and increases terminal differentiation into interfollicular epidermis and
sebaceous gland lineages 12,13. How c-Myc induces epidermal differentiation remains
unclear, but must depend in part on c-Myc’s transcriptional function.
Additional to its function as a transcription factor, c-Myc modulates the transcriptional
machinery 14. c-Myc stimulates promoter-paused Polymerase II to enter into productive
elongation at a large portion of active genes in embryonic stem cells 15,16. This observation,
together with the finding that c-Myc preferentially binds to promoter regions carrying active
chromatin marks 17,18, suggested that c-Myc contributes to expression of the majority of
active genes in a given cell context. In skin, c-Myc is known to functionally regulate
activated progenitor cells and might therefore contribute significantly to both proliferation
and differentiation programs.
Skin differentiation is an excellent system to explore the mechanisms by which c-Myc
regulates tissue homeostasis. Epidermal stem cells differentiate into hair follicles, sebaceous
glands, and interfollicular epidermis (IFE) — and differentiation into IFE can be promoted
by c-Myc 13. Proliferating IFE daughter cells execute terminal differentiation by migration
through suprabasal layers with progressive cornification 19. IFE differentiation genes are
clustered in mammalian genomes as the epidermal differentiation complex (EDC); the
mouse EDC is a single 2.2 Mb locus on chromosome 3 20,21. The EDC concentrates tissue-
specific genes, and thus facilitates the analysis of upstream regulatory networks.
We show that c-Myc determines the occurrence of transcriptional regulators and we
characterize their collective effect on gene expression. Using a combination of mouse
models and systems biology tools, we discover how a negative feedback loop between c-
Myc and Sin3A is required to balance proliferation and differentiation.
Results
EDC genes are bound and directly regulated by c-Myc
To better understand the paradox that activation of a proto-oncogene can lead to increased
differentiation (Fig. S1A-D) 2, we asked whether c-Myc directly regulated genes involved in
skin differentiation. We inducibly activated c-Myc in the basal, undifferentiated layer of the
mouse epidermis (K14MycER) and performed chromatin immunoprecipitation combined
with chromosome 3 tiling microarrays (ChIP on chip) capturing 61 genes in the EDC (http://
www.ensembl.org/index.html) (Fig. 1A). We detected widespread binding of c-Myc to EDC
genes, which over-lapped with H3K4me3, a histone mark that associates with active
transcription start sites (Fig. 1B). With the exception of loricrin (Lor) and trichohyalin
(Tchh), H3K4me3 and c-Myc binding excluded H3K27me3, an epigenetic mark that is
closely linked to transcriptional repression (Fig. 1B). Genome-wide analysis using proximal
promoter arrays confirmed that c-Myc and H3K4me3 occurrence overlapped by >80% and
remained unchanged between wild-type and transgenic animals (Fig. S1E,F; Table S1).
Most EDC genes (47/55) were expressed above background in wild type skin (Fig. 1C), and
17/55 were up-regulated after c-Myc activation (Fig. 1D; red bars). Conversely, RNA levels
of EDC genes were either unchanged or repressed in skin when c-Myc was conditionally
deleted (K14MycΔ/Δ) (Fig. 1D; blue bars). Direct c-Myc regulation of epidermal
differentiation was further evident when we analyzed RNA expression levels in c-Myc
depleted skin (Fig. S2A-C). Almost half of all genes that were more than two-fold down-
regulated when c-Myc was deleted were involved in epidermal maturation and
differentiation (Fig. S2A-C; Table S2).
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Cluster analysis confirmed that a set of EDC genes were up-regulated by 4-OHT driven c-
Myc activation (Fig. 2A). We confirmed a specific regulatory function of c-Myc on EDC
genes by comparing their change in RNA expression levels with randomly chosen non-EDC
genes (Fig. 2B). During the six day time course, EDC genes were only up-regulated after 4
to 6 days of 4-OHT treatment in K14MycER mice (Fig. 2A). The delay in the EDC’s
transcriptional response was unusual: virtually all transcriptional changes within the 5,000
genes most dependent on c-Myc activation occurred within one day of 4-OHT treatment
(Fig. 2C, Rasd2, Alox12; Table S3). In contrast, only 1.7% of genes were up-regulated after
4 to 6 days, which included the EDC genes (Fig. 2C, Lcn2; Table S3).
In contrast to the delay in transcriptional regulation, c-Myc bound to EDC genes within a
single day of 4-OHT treatment (Fig. S2D-F). This disconnection between rapid binding
followed by gradual up-regulation suggested that c-Myc control of EDC genes might require
additional tissue-specific transcription factors.
Myc modulates binding of tissue-specific transcription factors to the EDC
We characterized nine transcriptional regulators required for skin differentiation bind to the
mouse genome; AP2γ, C/EBPα and β, Ovol-1 and 2, Klf4, Sin3A, and Mxi1 (Fig.
3A,B) 22-28. Rbp2 was chosen as an H3K4-specific de-methylase 29. In c-Myc over-
expressing skin, specific clusters of transcription factors increased their shared occupancy of
the mouse genome after c-Myc activation (Fig. 3A,B; inserts; Table S4), which was even
more apparent within the 2.2 Mb containing the EDC (Fig. 3C,D). Here, we identified two
distinct clusters of transcription factor binding only apparent in K14MycER mice: one
contained Klf4, Ovol-1 and c-Myc, and the other Sin3A, Mxi1, and C/EBPα (Fig. 3C,D).
Occupancy of EDC genes by Klf4, Ovol-1, Sin3A, Mxi1 and C/EBPα depended directly on
the levels of c-Myc (Fig. 3E). Whereas tri-methylation of H3K4 and H3K27 was
comparable between transgenic and wild-type animals, binding of Ovol-1, Klf4, C/EBPα,
Mxi1 and Sin3A changed considerably when c-Myc was over-expressed (Fig. 3E). In wild-
type mice with low levels of c-Myc, EDC genes showed little Ovol-1 and Klf4 binding, but
were highly bound by C/EBPα, Mxi1 and Sin3A (Fig. 3E, left hand panel). When c-Myc
was over-expressed, binding of C/EBPα, Mxi1 and Sin3A was dramatically reduced;
conversely, the binding of Ovol-1 and Klf4 were enhanced (Fig. 3E; right hand panel). The
occurrence of transcription factors at EDC genes was not due to direct transcriptional up- or
down-regulation of the transcription factors by c-Myc, and transcription factors profiled here
were co-expressed within the same cellular sub-populations during epidermal differentiation
(Fig S3A-O). Thus, c-Myc regulates EDC genes by controlling the identity of transcriptional
partners present at EDC regulatory regions.
The dramatic binding changes of epidermal-specific transcription factors at the EDC
induced by c-Myc suggest that these factors collectively mediate transcriptional activity
(Fig. 3E). Among these regulators, only Sin3A principally acts as a transcriptional co-
repressor; we therefore considered the possibility that Sin3A directly displaces c-Myc to
antagonize its function.
Protein interaction with the Sin3A complex targets c-Myc for degradation
We first tested whether Sin3A and c-Myc interact on a protein level. Although we confirmed
that Sin3A co-immunoprecipitated with c-Myc (Fig. 4A), Sin3A and c-Myc binding to the
EDC was mutually exclusive in vivo (Fig. 3E), indicating that under physiological
conditions any interaction of Sin3A with c-Myc was transient. Because c-Myc expression in
wild-type epidermis is too low to perform co-immunoprecipitations, we asked how Sin3A
might remove c-Myc from the promoters.
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c-Myc activates transcription by forming a heterodimer with Max and recruitment of multi-
protein complexes including the histone acetyl transferases GCN5 and TIP60 30-32. Unlike
c-Myc, Max also heterodimerizes with Myc-antagonists of the Mxd (Mad) family 27,33,34.
Mxd-Max heterodimers repress transcription by recruiting Sin3A/histone deacetylase
complexes (HDACs) 35-37. Since the enzymatic activity of the Sin3A co-repressor complex
is mediated via HDACs, we speculated that the complex may inhibit acetylation of c-Myc.
Acetylation of c-Myc by GCN5 and TIP60 increases its protein stability and
transactivation 38.
Over-expression of GCN5 and TIP60 led to increased acetylation of c-Myc compared to
controls (Fig. 4B; Ac-Lys) 38. In contrast, acetylation of c-Myc was decreased in cells over-
expressing both the acetyltransferases and Sin3A (Fig. 4B; Ac-Lys). Western Blotting for c-
Myc, GCN5, TIP60 and Sin3A confirmed that the proteins were expressed at similar levels
(Fig. 4B). To test whether de-acetylation of c-Myc caused its degradation, we inhibited
protein translation using cycloheximide. The protein half-life of c-Myc was reduced when
Sin3A was co-expressed (Fig. 4C; Fig. S4A). c-Myc RNA levels were the same when GCN5
or Sin3A were over-expressed and GCN5 and Sin3A proteins were expressed equally (Fig.
S4B,C). Reporter assays demonstrated that transactivation of c-Myc was induced by GCN5
and reduced by Sin3A (Fig. 4D).
Depletion of Sin3A in skin induces proliferation and differentiation
To test whether Sin3A negatively regulates c-Myc target genes in vivo, we generated an
inducible, conditional knockout mouse model for Sin3A in the epidermis (Methods) (Fig.
S4D). We removed Sin3A by topical application of 4-OHT to the mouse back skin and
confirmed down-regulation of Sin3A on both RNA and protein level (Fig. S4E-G,L; Fig.
4I,J,L).
Application of 4-OHT in a time course led to an increase of thickness in the IFE (arrows)
and sebaceous glands (arrowheads) only in Sin3A-depleted skin (Fig. 4E-H; upper and
middle panels). Activation of Cre-recombinase in RosaLacZ reporter mice confirmed
homogenous recombination in the IFE after 5 days of 4-OHT treatment (Fig. 4E-H; lower
panels). Neither control mice nor mice with deleted Sin3B (K14Sin3BΔ/Δ) showed an
epidermal phenotype in response to 4-OHT treatment for 14 or 28 days, respectively (Fig.
S4H-J), excluding the possibility that the phenotype was due to nonspecific effects of Cre-
activity, and demonstrating that Sin3B is dispensable for skin homeostasis.
In wild-type skin, Sin3A was expressed throughout the IFE, the sebaceous glands and the
hair follicles (Fig. 4I). In tail skin IFE, Sin3A-positive nuclei were enriched towards the
basal, undifferentiated layers (Fig. S4K). Higher expression of Sin3A in undifferentiated
cells of the IFE was confirmed on RNA levels (Fig. S3I; left hand panel).
To confirm a transcriptional interaction between Sin3A and c-Myc in vivo, we isolated
epidermal cells from K14Sin3AΔ/Δ mice and tested whether acetylation levels of c-Myc
changed with deletion of Sin3A (Fig. 4K). Using ImageJ, we measured a 1.4-fold increase in
overall acetylation of c-Myc (Ac-Lys) relative to total c-Myc when Sin3A was absent (Fig.
4K). Accordingly, nuclear c-Myc was enriched in the IFE when Sin3A was deleted (Fig. 4L-
P; upper panels). Sin3A was highly expressed in both c-Myc depleted and over-expressing
skin (Fig. 4L; middle panel and M-P; lower panels).
Up-regulation of c-Myc in the absence of Sin3A led to enhanced proliferation in the IFE
(Fig. 5A-C). The number of Ki67-positive cells increased around 2-fold in both the IFE and
sebaceous glands (Fig. 5D,E). Analysis of the cell cycle revealed a significant increase in
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number of cells in S- and G2/M-phase upon treatment with 4-OHT (Fig. 5F), leading to
accumulation of Cyclin B1, UHRF1 and Mcm2 positive nuclei (Fig. 5G,H; Fig. S4M).
Whole mount labelling of tail skin demonstrated that BrdU incorporation in the IFE and
sebaceous glands was higher in K14Sin3AΔ/Δ mice than wild-type animals (Fig. 5I-L;
arrows). Thus, in contrast to recent findings in mouse embryonic fibroblasts in which
deletion of Sin3A caused proliferation arrest and apoptosis 39,40, loss of Sin3A in the
epidermis promoted cellular proliferation. This effect was not skin-specific and was also
found in testis and salivary glands (Fig. S5A-J).
To analyse whether the increased proliferation led to induced differentiation, we labelled
sections of back skin for the terminal differentiation markers keratin 10 (Krt10) and
involucrin (Ivl). Both markers increased in skin lacking Sin3A (Fig. 5M-P). Itgα6-positive,
undifferentiated layers of the epidermis were also increased upon Sin3A deletion (Fig. 5M-
P). Induced expression of markers for both undifferentiated and differentiated keratinocytes
in skin of K14Sin3AΔ/Δ mice was confirmed by QPCR (Fig. 5Q).
In summary, deletion of Sin3A in the epidermis increased cellularity in the IFE, which was
due to increased proliferation. This increase in cell division was accompanied by enhanced
differentiation, demonstrating that Sin3A is dispensable for cells to complete the epidermal
terminal differentiation program.
Loss of Sin3A leads to increased promoter occupancy of c-Myc at EDC genes
To test whether loss of Sin3A led to up-regulation of c-Myc-target genes, we performed
ChIP on chip experiments on chromosome 3 for c-Myc in skin of K14Sin3AΔ/Δ mice as
well as wild-type and K14MycER animals (Fig. 6A-C, blue bars; Table S5). Both, the
number of c-Myc bound genes and the peak signal, measured as maximal and average peak
signal of the combined data, increased when Sin3A was deleted compared to wild-type skin
(Fig. 6A-C, blue bars). The number of c-Myc bound genes commonly found in
K14Sin3AΔ/Δ and K14MycER but not wild-type epidermis increased more than two-fold
compared to the number of genes with c-Myc binding only found in wild-type and
K14MycER skin (Fig. 6D; Table S5).
We also compared Sin3A genomic occupancy in skin of wild-type mice or when c-Myc was
either deleted (K14MycΔ/Δ) or over-expressed (K14MycER) (Fig. 6A-C, red bars; Table
S5). The number of Sin3A peaks as well as the intensity of the signal in wild-type skin was
higher than in epidermis that either over-expressed or lacked c-Myc (Fig. 6A-C, red bars;
Fig. S6), indicating that a substantial number of Sin3A target genes required the presence of
c-Myc.
If our hypothesis that Sin3A detects and removes c-Myc from promoter regions replacing it
with antagonists of the Mxd-family was correct, binding of Mxi1 should similarly to Sin3A
depend on the presence and absence of c-Myc. Indeed, the overall number of binding events
of Mxi1 remained unchanged in wild-type versus K14Sin3AΔ/Δ epidermis (Fig. S7A, D-G;
Table S6). As expected, when c-Myc was over-expressed, the number of Mxi1-binding
events was reduced (Fig. S7A; Table S6). Furthermore, deletion of c-Myc led to an increase
of both maximum and average peak signal of Mxi1 across chromosome 3 (Fig. S7B,C).
Thus, similarly to Sin3A, enrichment of Mxi1 depended on the presence and absence of c-
Myc.
As described earlier, at EDC genes occurrence of Sin3A was highest in wild-type, lower in
epidermis that lacked c-Myc and absent in c-Myc over-expressing skin (Fig. 6E-G). In
contrast, binding of endogenous c-Myc was enriched on EDC genes when Sin3A was
Nascimento et al. Page 5
Nat Cell Biol. Author manuscript; available in PMC 2012 June 01.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
deleted (Fig. 6H). Thus, increased differentiation in K14Sin3AΔ/Δ transgenic mice might be
due to enhanced c-Myc-binding to EDC genes. Indeed, we found a highly similar pattern in
RNA expression levels of EDC genes in epidermis that either lacked Sin3A or over-
expressed c-Myc (Fig. 6I). Remarkably, c-Myc bound genes in K14Sin3AΔ/Δ epidermis
over-lapped up to 71% with Sin3A binding sites in wild-type skin (Fig. S8A; Table S5) and
only 18% of all c-Myc bound genes in K14MycER skin were never occupied by Sin3A in
wild-type or c-Myc-transgenic skin (Fig. S8B; Table S5).
Thus, absence of the Sin3A co-repressor complex in the epidermis can lead to an enhanced
genomic occupancy of c-Myc.
Sin3A and c-Myc co-operate in regulating genes involved in differentiation and
proliferation
We tested whether Sin3A also inhibited Myc-activity at target genes involved in cell growth
and proliferation. To identify genes that were commonly regulated by Sin3A and c-Myc, we
compared mRNA transcription in skin of both transgenic mouse models (Fig. 6J,K). First,
we identified 2187 genes that were potentially directly regulated by c-Myc by comparing c-
Myc binding with genes transcriptionally regulated in skin of K14MycER mice (Fig. 6J; left
hand panel; Table S7). Then, we identified 512 genes within this set that were also
differentially expressed in K14Sin3AΔ/Δ mice compared to control mice (Fig. 6K; left hand
panel; Table S7). Gene ontology analysis revealed highly similar gene categories for c-Myc-
only and c-Myc-Sin3A regulated genes (Fig. 6J,K; right hand panels) (http://
genetrail.bioinf.uni-sb.de/) 41. Promoter motif searches using the 2187 c-Myc-regulated and
the 512 c-Myc-Sin3A-regulated genes revealed a statistical significant over-representation
of c-Myc-Max binding sites (Fig. 6J,K; right hand panels) (http://159.149.109.9/pscan/) 42.
In line with our previous data Klf4 binding sites were also enriched in those genes (Table
S8).
We concluded that in addition to EDC genes many other genes involved in cell growth and
proliferation were regulated by c-Myc and Sin3A.
Deletion of c-Myc in K14Sin3AΔ/Δ mice restores tissue homeostasis
To test whether the phenotype in K14Sin3AΔ/Δ mice was solely dependent on c-Myc, we
generated a conditional double knockout mouse for Sin3A and c-Myc in the epidermis
(Methods) (Fig. 7). Deletion of c-Myc in K14Sin3AΔ/Δ transgenic mice
(K14MycΔ/ΔSin3AΔ/Δ) rescued the skin phenotype: the epidermis resembled that of control
mice (Fig. 7A-D). Down-regulation of c-Myc and Sin3A in this transgenic mouse was
confirmed by QPCR (Fig. 7E).
We confirmed that epidermal proliferation in the absence of c-Myc and Sin3A was similar
to controls by labelling cycling cells for Ki67 (Fig. 7A-D; lower panels and Fig. 7F). Indeed
after deletion of both Sin3A and c-Myc, a number of phenotypes reverted to near normal
levels: (i) expression of proliferation and cell cycle genes two-fold up-regulated by deletion
of Sin3A alone were now either wild-type levels or decreased (Fig 7G, left hand panel; Fig.
S8C); (ii) EDC gene expression perturbed by removal of Sin3A were closer to wild-type
levels (Fig. 7G; right hand panel); and, (iii) the balance of both undifferentiated and
differentiated epidermal layers was reverted to normal when both genes were deleted (Fig.
7H-O).
Together, the opposing effects of c-Myc and Sin3A on gene transcription are essential to
maintain normal skin homeostasis.
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Discussion
The underlying mechanisms for c-Myc-induced cellular differentiation are generally thought
to be indirect 2. Our data in mammalian epidermis indicates instead that c-Myc directly
controls genes involved in regulating differentiation. Myc directly binds to EDC genes at
regions enriched for trimethylation of H3K4 (H3K4me3), a chromatin mark found at active
genes, as well as a strong determinant for Myc-binding 17,18. The chromatin state does not
change after activation of c-Myc, supporting a model whereby the deposition of H3K4me3 is
independent of c-Myc 1,17.
The majority of transcriptional changes driven by c-Myc in the genome are immediate. In
contrast, the EDC genes directly bound by c-Myc demonstrate a substantial temporal lag in
their activation. One explanation for the delay in activation is that the regulatory landscape
within the EDC requires remodelling. We demonstrate that specific sets of transcription
factors must be removed, and others newly placed, after c-Myc activation. Thus, it appears
that c-Myc controls EDC transcription at two levels: it first directly binds EDC genes, but to
regulate gene expression, it then requires the formation of a differentiation-specific
regulatory transcription factor network.
The transcription factors recruited to the EDC included Klf4 and Ovol-1, both of which are
essential for proper barrier function in skin and both negatively regulate Myc-
expression 24,26,43. Thus, in later stages of differentiation, Klf4 and Ovol-1 may replace c-
Myc at EDC genes to complete the terminal differentiation program.
The transcription factors displaced from the EDC after c-Myc activation include C/EBPα,
Mxi1 and its co-repressor Sin3A. We further identify Sin3A as the major opposing factor to
c-Myc in controlling cellular proliferation and differentiation processes in skin. Sin3A is an
important regulator for the maintenance of the adult muscle and testis 44,45; and Sin3
complexes have been shown to spread immediately down-stream of transcription start sites
of both transcribed and repressed genes during myotube differentiation 46.
The exact biological role Sin3A plays in tissue-specific regulatory networks is not entirely
understood. Sin3A was originally identified as a co-repressor associated with the Mxd
family of c-Myc antagonists, and was shown to suppress epidermal proliferation 27,35-37. We
confirm this hypothesis by showing that tissue-specific deletion of Sin3A in the epidermis
induces cellular proliferation via a Myc-dependent pathway. Although, we cannot exclude
the possibility that loss of Sin3A in skin leads to a destabilization of the Myc-antagonist
repressor complex at chromatin, and thereby allows c-Myc to bind to promoter sequences,
we find that at least Mxi1’s binding to DNA is unaffected by the absence of Sin3A.
Sin3A is absent from promoter regions when c-Myc is over-expressed and is therefore
unable to form a stable repressor complex on chromatin when high levels of c-Myc are
bound. Thus, the interaction of Sin3A and c-Myc is most likely indirect via core proteins
mediating the de-acetylase enzymatic activity. Although we show that over-expression of
Sin3A causes de-acetylation of c-Myc, leading to decreased protein stability and reduced
transactivation, further studies will have to reveal the exact molecular pathway of how de-
acetylated c-Myc is degraded. Acetylation of c-Myc decreases its ubiquitination, and thus
de-acetylation may be linked to the ubiquitin proteosome pathway 47,48.
Although Sin3A limits cell proliferation, Sin3A is entirely dispensable for completion of the
terminal differentiation program. The inhibition of proliferation by Mxd-Sin3A complex has
been suggested as a mechanism to induce differentiation of primary human keratinocytes 28.
However, many non-proliferating cells in vivo are not terminally differentiated cells; for
example, in skin a large number of non-cycling, undifferentiated cells are tightly attached to
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the basement membrane 49. Thus, our data indicates that Sin3A is a proliferation inhibitor,
but this function is not coupled to terminal differentiation in skin.
Maintaining homeostasis in mammalian tissues is a balance to avoid over-proliferation or
under-proliferation, leading to cancer or tissue failure. How the mechanistic interplay
between transcriptional activators and repressors results in stability within tissues has been
poorly understood. We identify c-Myc and Sin3A as two master regulators in a mammalian
tissue, which can maintain cellular proliferation and differentiation processes by controlling
transcriptional balance between activation and repression.
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Appendix
Methods
Mouse lines and treatment with 4-OHT
All mouse husbandry and experiments were carried out according to the local ethics
committee under the terms of a UK Home Office license. All mouse lines were bred to a
mixed genetic background of CBA x C57BL/6J. The mouse line K14MycER was kindly
provided by F.M. Watt 13. KRT14-cre/Esr1 (The Jackson Laboratory) and Rosa26RLacZ-
Cre 50 lines were crossed with mice carrying floxed alleles for Sin3A, Sin3B, and c-Myc
and genotyped according to published protocols: Sin3Af/f 39, Sin3Bf/f 51 and Mycf/f 52.
Mouse back or tail skin was treated with 4-OHT as described previously 11,53. If not stated
otherwise K14MycER mice were treated with 4-OHT for four days, K14MycΔ/Δ mice for
21 days and K14Sin3AΔ/Δ mice for 15 days. Mice were either compared to 4-OHT treated
wild-type or vehicle treated (acetone) transgenic littermates.
Illumina gene expression microarrays
250 ng of total RNA was converted to complementary RNA (cRNA) target using the
Illumina TotalPrep-96 Kit (Ambion 4397949). Total RNA was reverse transcribed and
converted to double-stranded cDNA using a T7 promoter-Oligo(dT) primer and purified
with magnetic oligo(dT) beads. This formed the template for an in vitro transcription (IVT)
reaction which included a biotinylated nucleotide / ribonucleotide mix for both cRNA
amplification and biotin labeling. After purification, quality control and quantity
normalization the cRNA was hybridized to arrays (3 Sentrix BeadChip Array MouseWG-6
v2 Part #11278593). Hybridization, washing, staining and scanning were performed
according to standard Illlumina protocols (Illumina WGGX DirectHyb Assay Guide
11286331 RevA).
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ChIP on chip analysis
Back skin of six mice was pooled and used for one ChIP experiment. Isolation of primary
mouse keratinocytes and ChIP was performed as described previously 54. Sonicated
fractions were incubated with 10 to 15 μg of the following antibodies: c-Myc (sc-764, Santa
Cruz), H3K27me3 (07-449, Millipore), H4K3me3 (ab71998, Abcam or 04-745, Millipore),
C/EBPα (sc-9314, Santa Cruz), C/EBPβ (sc-150, Santa Cruz), Sin3A (sc-994, Santa Cruz),
Klf4 (sc-20691, Santa Cruz), Ovol-1 and Ovol-2 (kindly provided by X. Dai), AP2γ
(05-909, Millipore), Mxi1 (sc1042, Santa Cruz), and Rbp-2 (kindly provided by E.V.
Benevolenskaya).
Immunoprecipitated samples were washed at least four times with RIPA buffer [50 mM
HEPES pH 7.6, 1 mM EDTA, 0.7% (v/v) Na-deoxycholate, 1% (v/v) NP-40 and 0.5 M
LiCl] and once with TE buffer [50 mM Tris pH 8.0, 1 mM EDTA and 1% (w/v) SDS] at
4°C. Samples were eluted in 200 μl of SDS based elution buffer, diluted 1 volume in TE
buffer and treated with RNAse and Proteinase K. DNA was extracted with
phenol:chloroform and ethanol precipitated. ChIP samples were amplified by ligation
mediated PCR (LM-PCR) and Cy3-Cy5 labelled as described previously 55.
Microarray hybridization, washing and scanning was performed at the Genomics core
facility of CR-UK (CRI, Cambridge, UK) according to the standard protocols (http://
www.genomics.agilent.com/files/Manual/G4481-90010_MammalianProtocol_10.11.pdf).
ChIP on chip experiments were performed on mouse whole genome chromosome 3
(Amadid 15317) or proximal promoter Agilent arrays using a minimum of two independent
biological replicates.
Microarray and Data processing
Analysis of gene expression data involved the use of scripts written in R (R Development
Core Team 2008; www.r-project.org) and Bioconductor (www.bioconductor.org) 56.
Differential gene expression analysis was performed using limma 57 and time course
analysis using the time course package 58.
ChIP on chip data analysis was also carried out in R using bioconductor, specifically the
Ringo package 59. The R script used to analyse the ChIP on Chip data is provided as
supplementary material. To generate the scatterplots for the ChIP on chip raw data, the
mouse binding events for c-Myc were used as targets to center each window. A half size
window corresponding to 3000 bp was defined and we set a minimum number of 3 probes to
consider a binding event. Targets were predicted using a 0.90 quantile and genomic regions
between 1.0 kb upstream and 0.3 kb downstream of the transcription start site (TSS) of
annotated genes from the mouse genome (mm9) were used.
Clustering, annotation, and visualization
Microarray data were clustered using Euclidian distance and the “complete” agglomeration
method. These were visualized in R, using the gplots package (Warnes et al. 2010; http://
CRAN.R-project.org/package=gplots). Visualization of the time course of expression for
individual genes was also done in R.
Histology, BrdU labelling, tissue staining and cell cycle analysis
Tissues were fixed in 4% (w/v) paraformaldehyde and paraffin embedded or for
cryosections directly embedded in OCT (Raymond A Lamb). The tissue was sectioned at 5
to 10 μm for hematoxylin and eosin (H&E) staining or immunostaining as described
elsewhere 11,12.
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Immunohistochemistry was performed using Ventana Discovery (Ventana Medical Systems,
Inc) on paraffin embedded tissues fixed in 4% (w/v) paraformaldehyde, following
manufacturer’s guidelines. Antigen retrieval was performed using Ventana Cell
Conditioning 1 solution (Roche) for 40 minutes at 99°C. Primary antibody incubation was
performed for 54 minutes at 37°C. Secondary antibody incubation (Donkey anti-rabbit Ig
biotinylated, Jackson or Horse anti-goat Ig biotinylated Vector Labs) (1:1000) was
performed for 30 minutes at 37°C. Antibody detection was performed using the DAB Map
kit and sections were counterstained using hematoxylin and bluing reagent (Roche).
The primary antibodies used were Sin3A (1:50; sc-767, Santa Cruz), c-Myc (1:25; sc-769,
Santa Cruz), Ki67 (1:100; SP6, Vector Labs), Krt14 (1:250; PRB-155P Covance), BrDU
(1:100; Abcam), Krt10 (1:250; PRB-159P, Covance), Itga6 (1:250; GoH3 clone, Serotec),
Ivl (1:250; ERLI-3)53, Flg (1:250; PRB-417-P, Covance). Cyclin B1 (1:100; LS-C95967,
Lifespan Biosciences), UHRF1 (1:100; ab100810, Abcam), Mcm2 (1:100; LS B391,
Lifespan Biosciences), C/EBPα (1:100; sc-9314, Santa Cruz).
To determine the pattern of recombination at the Rosa26R reporter locus, β-galactosidase
analysis was performed in sectioned skin as described previously 9. For BrdU labeling, mice
were injected with 50 mg of BrdU per kg body weight and killed after 2 hours. Whole
mounts of mouse tail epidermis were prepared and labeled for immunofluorescence analysis
as described previously 53.
White field images were acquired using an Olympus IX80 microscope and a DP50 camera.
Confocal images were acquired on a Leica TCS SP5 confocal microscope. Z-stacks were
acquired at 100 Hz with an optimal stack distance and 1024x1024 dpi resolutions. Z-stack
projections were generated using the LAS AF software package (Leica Microsystems). All
the images were processed with Photoshop CS4 (Adobe) software.
For cell cycle analysis, cells were fixed with cold 70% (v/v) ethanol and washed with PBS
before being stained with propidium iodide (PI). After incubating the cells for 1 hour in
RNase, analysis was carried out on a CyAN ADP analyzer (Beckman Coulter). Cell cycle
profile was analysed using FlowJo software.
RNA extraction and semi-quantitative RT-PCR (QPCR)
RNA was isolated from total skin (epidermis and dermis) or cultured cells using trizol
reagent (Invitrogen) according to manufacturer’s instructions. Double stranded cDNA was
generated from 1 μg RNA using superscript III reverse transcriptase (Invitrogen) following
the manufacturer’s instructions. Real-time PCR amplification and analysis was conducted
using the 7900HT Real-Time PCR System (Applied Biosystems). The standard
amplification protocol was used with pre-designed probe sets and TaqMan Fast Universal
PCR Master Mix (2×) (Applied Biosystems). RNA levels were normalized to GAPDH
expression using the ΔCt method.
Cell culture, transient transfection, co-immunoprecipitation
The following constructs were cloned into eukaryotic expression vectors: estrogen receptor
domain fused to a Flag-tag (ER-Flag), human c-Myc fused to ER and Flag-tag (MycER-
Flag) 60, and full-length cDNA for Sin3A. The cytomegalovirus-driven expression vector
containing Tip60 was a kind gift from S. Khochbin, hGCN5 was kindly provided by S. Dent
and c-Myc was a kind gift of S. McMahon 38.
For luciferase assays, c-Myc, GCN5, Sin3A and the empty vector control were transfected
into HEK293 cells and the Myc reporter assays were performed according to the
manufacturer’s instructions (Cignal Myc Reporter; Qiagen).
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For c-Myc acetylation analysis, COS7 cells were grown in 150 mm2 dishes and transfected
at 50% confluence with the empty vector, or c-Myc, Tip60, hGCN5 and Sin3A constructs
with Lipofectamine LTX and Plus Reagent (Invitrogen) and harvested after 24 hours. To
detect endogenous acetylation levels of c-Myc, epidermal cells were isolated from back skin
of K14Sin3Af/f mice and cultured as described previously 11. Cells were treated with 4-OHT
or ethanol as a negative control and harvested after 48 hours.
All cells were harvested following trypsinisation and lysed in lysis buffer consisting of PBS
without Ca2+ and Mg2+, 0.5% (v/v) NP-40, 0.1% (w/v) sodium deoxycholate, 0.05% (w/v)
SDS and protease inhibitors (Roche). Lysates were then centrifuged at 16,000 x g for 10
minutes at 4°C and the supernatant was then added to Protein G Dynabeads (Invitrogen)
which had been pre-incubated with 4 μg of rabbit polyclonal anti c-Myc antibody (sc-764;
Santa Cruz) for 1 hour at 4°C. Following 2 hour incubation at 4°C, beads were washed 5
times with lysis buffer and immunoprecipitated protein was then eluted with SDS sample
buffer at 70°C. SDS-PAGE electrophoresis was then performed on 10% (w/v) gels and
proteins were then transferred onto nitrocellulose membranes. Western blotting was
followed by incubation with mouse monoclonal anti acetyl-lysine antibody (1:1000; Cell
Signalling Technology) to detect the amount of acetylated c-Myc. As controls, Western
blotting was also performed on whole cell lysates to detect the amount of total c-Myc
(1:250; sc-764, Santa Cruz), Tip60 (1:500: sc-5725, Santa Cruz), hGCN5 (1:500; sc-6303,
Santa Cruz), Sin3A (1:250; sc-994, Santa Cruz) and Tubulin (1:500; ab15246, Abcam). To
detect the Flag-tag we used ANTI-FLAG (1:500; M2, Sigma). Relative intensity of the
bands after Western blotting was performed using ImageJ.
Statistical Analysis
The significance of quantitative data was tested using the unpaired, two-tailed Student’s T
test.
Abbreviation for mouse lines
f/f floxed alleles
Δ/Δ deleted alleles
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Figure 1. Myc regulates genes involved in epidermal differentiation
(A) Genomic organisation of the mouse EDC. (B) Schematic over-view of H3K27me3 and
H3K4me3 occurrence and binding of c-Myc (blue) to EDC genes. (C) Expression of EDC
RNA levels in wild-type skin. (D) Fold change of EDC gene expression in K14MycER (red)
and K14MycΔ/Δ (red) mice normalized to wild-type animals.
Nascimento et al. Page 15
Nat Cell Biol. Author manuscript; available in PMC 2012 June 01.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Figure 2. Distinct expression profile for EDC genes in response to activated c-Myc
(A) Cluster analysis of RNA expression levels of EDC genes in K14MycER versus wild-
type controls treated with 4-OHT for the indicated time points in days (d). (B) Comparison
of EDC gene expression from (A) versus randomly selected non-EDC genes. (C) Common
expression profiles of 5000 regulated genes in triplicates in epidermis from K14MycER
(MycER1-3) and wild-type (WT1-3) mice. RNA expression of Rasd2 as one example for
46% of genes up-regulated after 1 day of 4-OHT treatment (left hand panel). Lcn2 as
representative gene for a small group of genes (1.7%) up-regulated after 4 days of 4-OHT
treatment (middle panel). Alox12 as an example for 46% of genes down-regulated after 1
day treatment with 4-OHT (right hand panel).
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Figure 3. Myc determines specific regulatory networks at the EDC
(A-D) Cluster analysis of binding events of the indicated tissue-specific transcription factors
to chromosome 3 (Chr3) (A,B) and the EDC-only (C,D) in skin of wild-type (A,C) and
K14MycER (B,D) mice. Heat maps show the number of shared binding events between two
transcription factors (light orange: low similarity and dark orange: high similarity of binding
sites occupied). Boxed inserts in (B) and (D) highlight specific clusters of transcriptional
regulators sharing a high number of binding events only when c-Myc is over-expressed. The
color codes are panel specific. (E) Occurrence of H3K4me3, H3K27me3 (grey) and
occupancy of transcription factors indicated to a group of EDC genes in wild-type (left hand
panel) and K14MyER mice (right hand panel). Over-expression of c-Myc leads to enhanced
binding of Klf4 and Ovol-1 (blue) and loss of binding of Sin3A, Mxi1 and C/EBPα (red).
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Figure 4. Sin3A causes de-acetylation of c-Myc and loss of Sin3A in skin causes increased
thickness of IFE and sebaceous glands
(A) Sin3A co-immunoprecipitates with Flag-tagged MycER (MycER-Flag) but not Flag-
tagged ER only (ER-Flag). The Western Blots were labelled using antibodies for Sin3A, c-
Myc and Flag. (B) Sin3A over-expression inhibits GCN5- and TIP60-mediated acetylation
of c-Myc. Cells transfected with the constructs indicated were immunoprecipitated for c-
Myc (IP; Myc). Acetylated c-Myc was detected by Western blotting using an antibody for
acetylated lysines (Ac-Lys). The empty vector (Ev) served as negative control. Western Blot
on whole cell lysates confirmed comparable protein levels of c-Myc, GCN5, TIP60 and
Sin3A. (C) Western Blot for c-Myc of cells over-expressing the empty vector control (Ev)
and c-Myc (Myc) or Myc and GCN5 or GCN5, c-Myc and Sin3A after treatment with
cycloheximide for the indicated hours. All blots are exposed for 20 seconds. Star marks
unspecific bands. (D) c-Myc luciferase reporter assay in cells expressing the empty vector
control (Ev), c-Myc, GCN5 and Sin3A. (+) indicates transfected with the corresponding
constructs; (-) means non-transfected. Error bars indicate s.d (n=4 experimental replicates).
(E-H) Effect of 4-OHT treatment for 1 (E), 5 (F), 9 (G), and 15 (H) days on skin of wild-
type (upper panels), K14Sin3AΔ/Δ (middle panels) and a Cre-reporter mouse
(RosaK14LacZ). (I,J) Skin sections from wild-type (I) and K14Sin3AΔ/Δ (J) mice labelled
with a Sin3A antibody. (K) Western Blot for Sin3A (upper panels), acetylated lysines of
immuno-precipitated c-Myc (middle panel) and total c-Myc (lower panel) in K14Sin3AΔ/Δ
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primary mouse keratinocytes treated with 4-OHT or ethanol (EtOH) as negative control. (L)
Protein expression of endogenous c-Myc and Sin3A in skin of the indicated transgenic or
wild-type mice. Tubulin (Tub) served as a loading control. (M-P) Skin sections from wild-
type and the indicated transgenic mice were stained for c-Myc (upper panels) and Sin3A
(lower panels). Dotted lines in (J,P) mark the basement membrane. Scale bars: 100 μm (E-
H, M-P). Uncropped images of blots are shown in Supplementary Figure S9.
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Figure 5. Sin3A-deletion causes epidermal proliferation and differentiation
(A-C) Labelling of cycling cells in IFE of wild-type mice (WT) (A), mice expressing
K14CreER only (K14Sin3Awt/wt) (B) and mice with deleted Sin3A (K14Sin3AΔ/Δ) (C)
using an antibody for Ki67 (brown). (D) Quantification of (A-C). (E) Quantification of
Ki67-positive cells in sebaceous glands. (F) Cell cycle profile of K14Sin3AΔ/Δ epidermal
cells treated with 4-OHT or acetone as a control. (G,H) Immunohistochmistry for Cyclin B1
(G) and UHRF1 (H) in wild-type (WT) (left hand panels) and K14Sin3AΔ/Δ (right hand
panels) skin. (I-L) Whole mount labelling of wild-type (WT) (I,K) and K14Sin3AΔ/Δ (J,L)
tail skin for cycling cells using an antibody for BrdU (green), keratin 14 (Krt14) (red).
Arrows indicate BrdU-positive nuclei in IFE (I,J) and sebaceous glands (K,L). (M-P) Skin
sections of wild-type (WT) (M,O) and K14Sin3AΔ/Δ (N,P) labelled for Itgα6 (green),
keratin 10 (Krt10) (red) (M,N) and involucrin (Ivl) (red) (O,P). Nuclei are counter-stained
with DAPI (blue) (M-P). (Q) QPCR for RNA expression for the indicated genes in skin of
wild-type (WT) and K14Sin3AΔ/Δ (Sin3AΔ/Δ) animals. Scale bars: 25 μm (A-C); 100 μm
(G,H); 250 μm (I,J); 75 μm (K,L); 50 μm (M-P). Error bars in indicate s.d (D-F: n=5
animals of each mouse line; Q: n= 3 biological replicates averaged over 3 technical
replicates each).
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Figure 6. Re-activation of Myc-target genes in response to Sin3A-deletion
(A-C) ChIP on chip analysis on chromosome 3 using c-Myc (blue) and Sin3A (red)
antibodies using skin of wild-type and indicated transgenic animals. Shown are the total
number of bound genes (A), the maximal peak signal (B), and the average peak signal (C) of
the combined replicates. (D) Venn diagram (http://www.pangloss.com/seidel/Protocols/
venn.cgi) shows increase of c-Myc-binding to genes on chromosome 3 in the absence of
Sin3A (K14Sin3AΔ/Δ) compared to control (wild-type). (E-H) Binding of c-Myc (blue) and
Sin3A (red) to EDC genes in skin of K14MycER (E), K14MycΔ/Δ (F), wild-type (G) and
K14Sin3AΔ/Δ (H) mice. (I) Change of RNA expression levels of EDC genes in
K14Sin3AΔ/Δ (red) and K14MycER (blue) mice relative to wild-type mice. (J) Gene
ontology categorization of c-Myc-regulated genes by comparing ChIP on chip data with
gene expression arrays obtained from K14MycER and control skin after treatment with 4-
OHT for 4 days. P-value indicates the statistical significance for over-representation of c-
Myc-Max binding sites in the 2187 c-Myc-regulated genes. (K) Gene ontology
categorization of c-Myc and Sin3A regulated genes by comparing c-Myc-regulated genes
from (I) with differentially expressed genes in K14Sin3AΔ/Δ mice compared to controls
after treatment with 4-OHT for 14 days. P-value for over-representation of c-Myc-Max
binding sites in the 512 c-Myc/Sin3A-regulated genes.
Nascimento et al. Page 21
Nat Cell Biol. Author manuscript; available in PMC 2012 June 01.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Figure 7. Deletion of c-Myc reverts proliferation and differentiation to normal in skin lacking
Sin3A
(A-D) Hematoxylin and Eosin staining (upper panels) and Ki67 labelling (lower panels) of
skin sections when Sin3A is deleted (A) (K14Mycwt/Δ Sin3A Δ/Δ), when both c-Myc and
Sin3A are deleted (B) (K14MycΔ/Δ Sin3AΔ/Δ), when only c-Myc is deleted (C)
(K14MycΔ/ΔSin3Awt/Δ), and when no Cre-recombinase is expressed (D) (Mycf/f Sin3Af/f).
Effect of c-Myc and/or Sin3A-deletion on gene-expression is indicated in upper row. (E)
QPCR for c-Myc (left hand panel) and Sin3A (right hand panel) RNA in skin of mice
indicated in (A-D). (F) Quantification of Ki67 staining from (A-D). Error bars indicate s.d
(E: n= 3 biological replicates averaged over 3 technical replicates each; F: n=5 animals of
each mouse line). (G) Fold change of expression of genes categorised as cell proliferation
(left hand panel) and EDC genes (right hand panel) in skin when only Sin3A is deleted
(K14Sin3AΔ/Δ, red) or both c-Myc and Sin3A are deleted (K14Myc/Sin3AΔ/Δ, blue)
normalized to the corresponding wild-type (WT) controls. (H-O) Protein expression of
keratin 14 (Krt14) (red) (H,I) and Itgα6 (green) (L,M) as markers for undifferentiated
epidermal cells and Krt 10 (green) (J,K) and filaggrin (Flg) (red) (N,O) as markers for
terminal differentiated cells are reverted to normal when both c-Myc and Sin3A are deleted
(K14MycΔ/ΔSin3AΔ/Δ) (I,M,K,O) compared to single deletion of Sin3A (K14Mycwt/Δ
Sin3AΔ/Δ) (H,L,J,N). White line in (H,I,L,M) indicates thickness of the IFE. Dotted white
line in (J,K,N,O) indicates the basement membrane. Nuclei are counter-stained with DAPI
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(blue) (H-O). Scale bars: 100 μm (A-D; upper hand panels); 25 μm (A-D; lower hand
panels); 50 μm (H-O).
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